Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9429)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2014 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ma HC, Shi XL, Ren HZ, Yuan XW, Ding YT. Targeted migration of mesenchymal stem cells modified with CXCR4 to acute failing liver improves liver regeneration. World J Gastroenterol 2014; 20(40): 14884-14894 [PMID: 25356048 DOI: 10.3748/wjg.v20.i40.14884] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i40/14884.htm |
| Number | Citing Articles |
| 1 |
Nina Kosaric, Geoffrey C. Gurtner. Reference Module in Biomedical Sciences. 2018; doi: 10.1016/B978-0-12-801238-3.65452-1
|
| 2 |
Jian-Feng Sang, Xiao-Lei Shi, Bin Han, Tao Huang, Xu Huang, Hao-Zhen Ren, Yi-Tao Ding. Intraportal mesenchymal stem cell transplantation prevents acute liver failure through promoting cell proliferation and inhibiting apoptosis. Hepatobiliary & Pancreatic Diseases International 2016; 15(6): 602 doi: 10.1016/S1499-3872(16)60141-8
|
| 3 |
Mohammed Alfaifi, Young Woo Eom, Philip N. Newsome, Soon Koo Baik. Mesenchymal stromal cell therapy for liver diseases. Journal of Hepatology 2018; 68(6): 1272 doi: 10.1016/j.jhep.2018.01.030
|
| 4 |
Krzysztof Łukowicz, Barbara Zagrajczuk, Karolina Truchan, Łukasz Niedzwiedzki, Katarzyna Cholewa-Kowalska, Anna M. Osyczka. Chemical Compounds Released from Specific Osteoinductive Bioactive Materials Stimulate Human Bone Marrow Mesenchymal Stem Cell Migration. International Journal of Molecular Sciences 2022; 23(5): 2598 doi: 10.3390/ijms23052598
|
| 5 |
Mu-Chen Wu, Qing-Hua Meng. Current understanding of mesenchymal stem cells in liver diseases. World Journal of Stem Cells 2021; 13(9): 1349-1359 doi: 10.4252/wjsc.v13.i9.1349
|
| 6 |
Kun Wang, Yuwen Li, Tiantian Zhu, Yongting Zhang, Wenting Li, Wenyu Lin, Jun Li, Chuanlong Zhu. Overexpression of c-Met in bone marrow mesenchymal stem cells improves their effectiveness in homing and repair of acute liver failure. Stem Cell Research & Therapy 2017; 8(1) doi: 10.1186/s13287-017-0614-2
|
| 7 |
Lukun Zhou, Shuang Liu, Zhao Wang, Jianfeng Yao, Wenbin Cao, Shulian Chen, Wenjun Xie, Shuqing Feng, Yuanfu Xu, Tao Cheng, Mingzhe Han, Sizhou Feng. Bone Marrow-Derived Mesenchymal Stem Cells Modified with Akt1 Ameliorates Acute Liver GVHD. Biological Procedures Online 2019; 21(1) doi: 10.1186/s12575-019-0112-2
|
| 8 |
Shuang Lyu, Shuirong Liu, Xin Guo, Yaolei Zhang, Zhongyu Liu, Shan Shi, Wenya Li, Juan Pei, Yonghong Fan, Hongyu Sun. hP-MSCs attenuate severe acute pancreatitis in mice via inhibiting NLRP3 inflammasome-mediated acinar cell pyroptosis. Apoptosis 2024; 29(5-6): 920 doi: 10.1007/s10495-024-01946-5
|
| 9 |
Catarina M. Trigo, Joana S. Rodrigues, Sérgio P. Camões, Susana Solá, Joana P. Miranda. Mesenchymal stem cell secretome for regenerative medicine: Where do we stand?. Journal of Advanced Research 2024; doi: 10.1016/j.jare.2024.05.004
|
| 10 |
Catherine Sullivan. The Biology and Therapeutic Application of Mesenchymal Cells. 2016; : 286 doi: 10.1002/9781118907474.ch22
|
| 11 |
Asieh Heirani-Tabasi, Shirin Toosi, Mahdi Mirahmadi, Mohammad Amir Mishan, Hamid Reza Bidkhori, Ahmad Reza Bahrami, Javad Behravan, Hojjat Naderi-Meshkin. Chemokine Receptors Expression in MSCs: Comparative Analysis in Different Sources and Passages. Tissue Engineering and Regenerative Medicine 2017; 14(5): 605 doi: 10.1007/s13770-017-0069-7
|
| 12 |
Ling Dai, Xiang Gao, Zhihua Ye, Hanmin Li, Xin Yao, Dingbo Lu, Na Wu. The “Traditional Chinese medicine regulating liver regeneration” treatment plan for reducing mortality of patients with hepatitis B-related liver failure based on real-world clinical data. Frontiers of Medicine 2021; 15(3): 495 doi: 10.1007/s11684-020-0790-9
|
| 13 |
Samin Shokravi, Vitaliy Borisov, Burhan Abdullah Zaman, Firoozeh Niazvand, Raheleh Hazrati, Meysam Mohammadi Khah, Lakshmi Thangavelu, Sima Marzban, Armin Sohrabi, Amir Zamani. Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review. Stem Cell Research & Therapy 2022; 13(1) doi: 10.1186/s13287-022-02825-z
|
| 14 |
Qiu-Yun Li, Juan Chen, Yong-Heng Luo, Wei Zhang, En-Hua Xiao. Sodium Butyrate Pre-Treatment Enhance Differentiation of Bone
Marrow Mesenchymal Stem Cells (BM-MSCs) into Hepatocytes and
Improve Liver Injury. Current Molecular Medicine 2022; 22(7): 663 doi: 10.2174/1566524021666211014161716
|
| 15 |
Shota Yamada, Kaori Yamada, Ayae Sugawara-Narutaki, Yoshinobu Baba, Hiroshi Yukawa. Near-infrared-II fluorescence/magnetic resonance double modal imaging of transplanted stem cells using lanthanide co-doped gadolinium oxide nanoparticles. Analytical Sciences 2024; 40(6): 1043 doi: 10.1007/s44211-024-00507-9
|
| 16 |
G. Amato, T. Saleh, G. Carpino, E. Gaudio, D. Alvaro, V. Cardinale. Cell Therapy and Bioengineering in Experimental Liver Regenerative Medicine: In Vivo Injury Models and Grafting Strategies. Current Transplantation Reports 2021; 8(2): 76 doi: 10.1007/s40472-021-00325-2
|
| 17 |
Mohammad Saeed Kahrizi, Elnaz Mousavi, Armin Khosravi, Sara Rahnama, Ali Salehi, Navid Nasrabadi, Farnoosh Ebrahimzadeh, Samira Jamali. Recent advances in pre-conditioned mesenchymal stem/stromal cell (MSCs) therapy in organ failure; a comprehensive review of preclinical studies. Stem Cell Research & Therapy 2023; 14(1) doi: 10.1186/s13287-023-03374-9
|
| 18 |
|
| 19 |
Panpan Cen, Jiajia Chen, Chenxia Hu, Linxiao Fan, Jie Wang, Lanjuan Li. Noninvasive in-vivo tracing and imaging of transplanted stem cells for liver regeneration. Stem Cell Research & Therapy 2016; 7(1) doi: 10.1186/s13287-016-0396-y
|
| 20 |
Nannan Zhang, Li Zhao, Daijiang Liu, Chaoqun Hu, Yi Wang, Tongchuan He, Yang Bi, Yun He. Characterization of Urine-Derived Stem Cells from Patients with End-Stage Liver Diseases and Application to Induced Acute and Chronic Liver Injury of Nude Mice Model. Stem Cells and Development 2021; doi: 10.1089/scd.2021.0137
|
| 21 |
Xin Zhao, Xiaolei Shi, Zhiheng Zhang, Hucheng Ma, Xianwen Yuan, Yitao Ding. Combined treatment with MSC transplantation and neutrophil depletion ameliorates D-GalN/LPS-induced acute liver failure in rats. Clinics and Research in Hepatology and Gastroenterology 2016; 40(6): 730 doi: 10.1016/j.clinre.2016.04.003
|
| 22 |
Lu Wang, Shu Li, Han-Yu Wang, Juan Zeng, Zheng-Zheng Zhang, Dong-Yong Lv, Wei-Hong Kuang. In a Rat Model of Acute Liver Failure, Icaritin Improved the Therapeutic Effect of Mesenchymal Stem Cells by Activation of the Hepatocyte Growth Factor/c-Met Pathway. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/4253846
|
| 23 |
Sheng Wang, Songsen Gao, Yueran Li, Xueyi Qian, Jiajie Luan, Xiongwen Lv. Emerging Importance of Chemokine Receptor CXCR4 and Its Ligand in Liver Disease. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.716842
|
| 24 |
Yong-Hong Wang, En-Qiang Chen. Mesenchymal Stem Cell Therapy in Acute Liver Failure. Gut and Liver 2023; 17(5): 674 doi: 10.5009/gnl220417
|
| 25 |
Chengmei He, Yanlei Yang, Kunyu Zheng, Yiran Chen, Suying Liu, Yongzhe Li, Qin Han, Robert Chunhua Zhao, Li Wang, Fengchun Zhang. Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges. Therapeutic Advances in Chronic Disease 2021; 12 doi: 10.1177/2040622321993442
|
| 26 |
Hailing Liao, Siying Du, Ting Jiang, Mengyao Zheng, Zhao Xiang, Jinhui Yang. UMSCs Attenuate LPS/D-GalN-Induced Acute Liver Failure in Mice by Down-regulating the MyD88/NF-κB Pathway. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00157
|
| 27 |
Anjum Mahmood, Rajasekar Seetharaman, Prashant Kshatriya, Divyang Patel, Anand S. Srivastava. Stem Cell Transplant for Advanced Stage Liver Disorders: Current Scenario and Future Prospects. Current Medicinal Chemistry 2020; 27(37): 6276 doi: 10.2174/0929867326666191004161802
|
| 28 |
Adam Nowakowski, Piotr Walczak, Barbara Lukomska, Miroslaw Janowski, Paulo Henrique Rosado de Castro. Genetic Engineering of Mesenchymal Stem Cells to Induce Their Migration and Survival. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/4956063
|
| 29 |
Farnaz Sani, Mahsa Sani, Zahra Moayedfard, Maryam Darayee, Lobat Tayebi, Negar Azarpira. Potential advantages of genetically modified mesenchymal stem cells in the treatment of acute and chronic liver diseases. Stem Cell Research & Therapy 2023; 14(1) doi: 10.1186/s13287-023-03364-x
|
| 30 |
Bruno Christ, Sandra Brückner, Sandra Winkler. The Therapeutic Promise of Mesenchymal Stem Cells for Liver Restoration. Trends in Molecular Medicine 2015; 21(11): 673 doi: 10.1016/j.molmed.2015.09.004
|
| 31 |
Xiaoguang Chen, Xuemin Zhu, Yumei Liu, Qiongxia Lv, Jun Ma. Silencing of phospholipase C gamma 2 promotes proliferation of rat hepatocytes in vitro. Journal of Cellular Biochemistry 2018; 119(5): 4085 doi: 10.1002/jcb.26592
|
| 32 |
Hao-ran Ding, Jing-lin Wang, Zhen-ting Tang, Yue Wang, Guang Zhou, Yang Liu, Hao-zhen Ren, Xiao-lei Shi. Mesenchymal Stem Cells Improve Glycometabolism and Liver Regeneration in the Treatment of Post-hepatectomy Liver Failure. Frontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.00412
|
| 33 |
Chenxia Hu, Lanjuan Li. In VitroandIn VivoHepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver Diseases. Stem Cells International 2015; 2015: 1 doi: 10.1155/2015/871972
|
| 34 |
Shota Yamada, Hiroshi Yukawa, Kaori Yamada, Yuki Murata, Jun-ichiro Jo, Masaya Yamamoto, Ayae Sugawara-Narutaki, Yasuhiko Tabata, Yoshinobu Baba. In Vivo Multimodal Imaging of Stem Cells Using Nanohybrid Particles Incorporating Quantum Dots and Magnetic Nanoparticles. Sensors 2022; 22(15): 5705 doi: 10.3390/s22155705
|
| 35 |
Chenxia Hu, Lanjuan Li. Improvement of mesenchymal stromal cells and their derivatives for treating acute liver failure. Journal of Molecular Medicine 2019; 97(8): 1065 doi: 10.1007/s00109-019-01804-x
|
| 36 |
Xue Yang, Yan Meng, Zhipeng Han, Fei Ye, Lixin Wei, Chen Zong. Mesenchymal stem cell therapy for liver disease: full of chances and challenges. Cell & Bioscience 2020; 10(1) doi: 10.1186/s13578-020-00480-6
|
| 37 |
Qian Wang, Yuwen Li, Hui Yuan, Linya Peng, Zixing Dai, Ye Sun, Rui Liu, Wenting Li, Jun Li, Chuanlong Zhu. Hypoxia preconditioning of human amniotic mesenchymal stem cells enhances proliferation and migration and promotes their homing via the HGF/C-MET signaling axis to augment the repair of acute liver failure. Tissue and Cell 2024; 87: 102326 doi: 10.1016/j.tice.2024.102326
|
| 38 |
Nina Kosaric, Harriet Kiwanuka, Geoffrey C Gurtner. Stem cell therapies for wound healing. Expert Opinion on Biological Therapy 2019; 19(6): 575 doi: 10.1080/14712598.2019.1596257
|
| 39 |
Chaturvedula Tripura, Srinivas Gunda, Sandeep Kumar Vishwakarma, Avinash Raj Thatipalli, Jedy Jose, Mahesh Kumar Jerald, Aleem Ahmed Khan, Gopal Pande. Long-term and non-invasive <i>in vivo</i> tracking of DiD dye-labeled human hepatic progenitors in chronic liver disease models. World Journal of Hepatology 2022; 14(10): 1884-1898 doi: 10.4254/wjh.v14.i10.1884
|
| 40 |
Chien-Wei Lee, Yu-Fan Chen, Hao-Hsiang Wu, Oscar K. Lee. Historical Perspectives and Advances in Mesenchymal Stem Cell Research for the Treatment of Liver Diseases. Gastroenterology 2018; 154(1): 46 doi: 10.1053/j.gastro.2017.09.049
|
| 41 |
Jian-Feng Sang, Xiao-Lei Shi, Bing Han, Xu Huang, Tao Huang, Hao-Zhen Ren, Yi-Tao Ding. Combined mesenchymal stem cell transplantation and interleukin-1 receptor antagonism after partial hepatectomy. World Journal of Gastroenterology 2016; 22(16): 4120-4135 doi: 10.3748/wjg.v22.i16.4120
|
| 42 |
Shota Yamada, Hiroshi Yukawa, Koudai Kitamura, Toshiki Mizumaki, Yasuma Yoshizumi, Tomomi Oohara, Eri Nanizawa, Fumika Hirano, Kazuhide Sato, Ayae Sugawara-Narutaki, Tetsuya Ishikawa, Yoshinobu Baba. In Vivo Real-Time Quantum Dots Imaging to Track Transplanted Adipose Stem Cells in Different Inflammatory States of Acute Liver Failure Mice. Cell Transplantation 2023; 32 doi: 10.1177/09636897231176442
|
| 43 |
L. da Silva Meirelles, N.B. Nardi. Mesenchymal Stromal Cells as Tumor Stromal Modulators. 2017; : 155 doi: 10.1016/B978-0-12-803102-5.00006-9
|
| 44 |
|
| 45 |
Yuzo Koda, Nobuhiro Nakamoto, Po-Sung Chu, Toshiaki Teratani, Akihisa Ueno, Takeru Amiya, Nobuhito Taniki, Sayako Chiba, Kentaro Miyamoto, Michiie Sakamoto, Takanori Kanai. CCR9 axis inhibition enhances hepatic migration of plasmacytoid DCs and protects against liver injury. JCI Insight 2022; 7(17) doi: 10.1172/jci.insight.159910
|
| 46 |
Pan-Pan Cen, Lin-Xiao Fan, Jie Wang, Jia-Jia Chen, Lan-Juan Li. Therapeutic potential of menstrual blood stem cells in treating acute liver failure. World Journal of Gastroenterology 2019; 25(41): 6190-6204 doi: 10.3748/wjg.v25.i41.6190
|
| 47 |
|
| 48 |
Hu-Cheng Ma, Xin Wang, Min-Na Wu, Xin Zhao, Xian-Wen Yuan, Xiao-Lei Shi. Interleukin-10 Contributes to Therapeutic Effect of Mesenchymal Stem Cells for Acute Liver Failure via Signal Transducer and Activator of Transcription 3 Signaling Pathway. Chinese Medical Journal 2016; 129(8): 967 doi: 10.4103/0366-6999.179794
|
| 49 |
Amir K. Varkouhi, Ana Paula Teixeira Monteiro, James N. Tsoporis, Shirley H. J. Mei, Duncan J. Stewart, Claudia C. dos Santos. Genetically Modified Mesenchymal Stromal/Stem Cells: Application in Critical Illness. Stem Cell Reviews and Reports 2020; 16(5): 812 doi: 10.1007/s12015-020-10000-1
|
| 50 |
Masahiro Iseki, Yoshihiro Kushida, Shohei Wakao, Takahiro Akimoto, Masamichi Mizuma, Fuyuhiko Motoi, Ryuta Asada, Shinobu Shimizu, Michiaki Unno, Gregorio Chazenbalk, Mari Dezawa. Human Muse Cells, Nontumorigenic Phiripotent-Like Stem Cells, Have Liver Regeneration Capacity through Specific Homing and Cell Replacement in a Mouse Model of Liver Fibrosis. Cell Transplantation 2017; 26(5): 821 doi: 10.3727/096368916X693662
|
| 51 |
Yalan Yang, Zhaohui Zhong, Yubin Ding, Wanfeng Zhang, Yang Ma, Li Zhou. Bioinformatic identification of key genes and pathways that may be involved in the pathogenesis of HBV-associated acute liver failure. Genes & Diseases 2018; 5(4): 349 doi: 10.1016/j.gendis.2018.02.005
|
| 52 |
Julie R. Beegle, Jan A. Nolta, Fernando A. Fierro. The Biology and Therapeutic Application of Mesenchymal Cells. 2016; : 873 doi: 10.1002/9781118907474.ch61
|
| 53 |
Dan Qin, Yi Yan, Bian Hu, Wanpo Zhang, Hanmin Li, Xiaodong Li, Shenghui Liu, Depeng Dai, Xiongji Hu, Xingxu Huang, Lisheng Zhang. Wisp2 disruption represses Cxcr4 expression and inhibits BMSCs homing to injured liver. Oncotarget 2017; 8(58): 98823 doi: 10.18632/oncotarget.22006
|
| 54 |
Yong-Hong Wang, Dong-Bo Wu, Bing Chen, En-Qiang Chen, Hong Tang. Progress in mesenchymal stem cell–based therapy for acute liver failure. Stem Cell Research & Therapy 2018; 9(1) doi: 10.1186/s13287-018-0972-4
|
| 55 |
Camelia-Mihaela Zară-Dănceanu, Anca-Emanuela Minuti, Cristina Stavilă, Luminiţa Lăbuscă, Dumitru-Daniel Herea, Crina Elena Tiron, Horia Chiriac, Nicoleta Lupu. Magnetic Nanoparticle Coating Decreases the Senescence and Increases the Targeting Potential of Fibroblasts and Adipose-Derived Mesenchymal Stem Cells. ACS Omega 2023; 8(26): 23953 doi: 10.1021/acsomega.3c02449
|